C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1992
12/23/1992	EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt
12/23/1992	EP0519011A1 Protein expression via seed specific regulatory sequences
12/23/1992	EP0519008A1 Interleukin-4 binding proteins
12/23/1992	EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/23/1992	EP0518933A1 Leukaemia inhibitory factor
12/23/1992	EP0262192B1 Method and means for producing a protein having the same igg specificity as protein g
12/23/1992	CA2111681A1 Mimic peptides of gp120
12/23/1992	CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	CA2111472A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	CA2111456A1 Recombinant immunogenic actinomycetale
12/23/1992	CA2111348A1 Production of human hemoglobin in transgenic pigs
12/23/1992	CA2111217A1 Insertional mutations in mycobacteria
12/23/1992	CA2111110A1 Production and recovery of recombinant neurotrophins
12/23/1992	CA2111108A1 Hepatitis c diagnostics and vaccines
12/23/1992	CA2110799A1 Microbially-produced antibody fragments and their conjugates
12/23/1992	CA2110591A1 Polynucleotide determination with selectable cleavage sites
12/23/1992	CA2110489A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992	CA2103377A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/23/1992	CA2088766A1 Use of exo-sample nucleotides in gene cloning
12/22/1992	US5173428 Genetically engineered Pseudomonas strains lacking active plasmidic alkanol dehydrogenase gene
12/22/1992	US5173426 Pure polynucleotide; for increasing tissue oxygenation in patients
12/22/1992	US5173425 Transforming host cell with DNA sequence that encodes two ferredoxin polypeptides for each reductase polypeptide and iron-sulfur polypeptide by growing transformed organisms in the presence of iron
12/22/1992	US5173420 Monoclonal antibody recognizing un-natural ganglioside gd3
12/22/1992	US5173418 Production in Escherichia coli of extracellular Serratia spp. hydrolases
12/22/1992	US5173414 Production of recombinant adeno-associated virus vectors
12/22/1992	US5173410 Providing a complementary DNA sequence corresponding to the RNA transscript desired attached to a promoter sequence, replicating DNA, placing replicated DNA in a vitro environment comprising RNA polymerase and isolating RNA transcripts
12/22/1992	US5173408 Mammalian pancreatic cholesterol esterase
12/22/1992	US5173403 Thermostable acid protease from sulfolobus acidocaldarius and gene
12/22/1992	US5173297 Bacteriocin from lactococcus lactis subspecies lactis
12/22/1992	US5173294 Purified antiserum which recognizes homophilus influenzae outer membrane protein for treating diseases caused by pathogen
12/22/1992	US5173158 Trapping cells in pores of insulating film in container, applying electrical field
12/22/1992	CA2071622A1 Anti-tcf-ii monoclonal antibodies and method for the measurement of tcf-ii by applying the antibodies
12/20/1992	CA2071473A1 Receptor protein kinase gene encoded at the self-incompatibility locus
12/19/1992	CA2071395A1 Coccidiosis poultry vaccine
12/19/1992	CA2071305A1 Anti-hiv antibodies
12/19/1992	CA2065919A1 Leydig cell stimulator
12/17/1992	DE4119574A1 Storage and/or transportation of nucleic acids in undissolved form - by binding acids reversibly to mineral solid, e.g. silica gel or glass
12/16/1992	EP0518757A1 Peptides or polypeptides of BVD and related viruses
12/16/1992	EP0518756A1 Procedure to detect a bovine viral diarrhoea virus infection, nucleotide sequence coding for a protein induced by infection with this virus and recombinant proteins and antigens resulting from same
12/16/1992	EP0518650A2 Sequence specific DNA binding by P53
12/16/1992	EP0518587A2 A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
12/16/1992	EP0518583A1 Nucleotide sequences
12/16/1992	EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
12/16/1992	EP0518313A2 Gene of hepatitis C virus or fragment thereof, polypeptide encoded by the same
12/16/1992	EP0518277A2 Method for separating and culturing fused hybrid cells
12/16/1992	EP0518096A1 Yogurt containing living microorganisms
12/16/1992	EP0517931A1 Physiologically active peptides, use thereof and a method of producing said peptides
12/16/1992	EP0517925A1 Novel megakaryocyte amplifier and production thereof
12/16/1992	EP0517909A1 Modified hepatocytes and uses therefor
12/16/1992	EP0517859A1 Oligonucleotide therapies for modulating the effects of herpesviruses
12/16/1992	EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
12/16/1992	EP0517833A1 Regeneration and genetic transformation of sugar beet.
12/16/1992	EP0517829A1 Improved chimeric toxins
12/16/1992	EP0517826A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME
12/16/1992	EP0517815A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE
12/16/1992	EP0517805A1 Identification and expression of insect steroid receptor dna sequences
12/16/1992	EP0517790A1 Method for enhancing recovery of recombinant proteins
12/16/1992	EP0517779A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-$g(b)1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN
12/16/1992	EP0517768A1 Mammalian expression vectors
12/16/1992	EP0517754A1 Antibody constructs with enhanced binding affinity
12/16/1992	EP0517751A1 Shuttle plasmid for escherichia coli and mycobacteria
12/15/1992	WO1992022663A1 Amplification of nucleic acid molecules
12/15/1992	US5171850 Intestinal oncofetal gene
12/15/1992	US5171844 For use in treating hemophilia
12/15/1992	US5171841 T-cell suppressor protein
12/15/1992	US5171840 Receptor protein for human B cell stimulatory factor-2
12/15/1992	US5171839 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
12/15/1992	US5171739 Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
12/15/1992	US5171684 Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1
12/15/1992	US5171682 Purified Bacillus licheniformis PWD-1 keratinase
12/15/1992	US5171680 Having tetrapeptide domain available to access target tissue; cultrue product; antiishemic, antiinflammatory
12/15/1992	US5171678 Lipopolyamines, their preparation and their use
12/15/1992	US5171677 Recombinant marek's disease virus and process for preparing the same
12/15/1992	US5171675 Macrophage colony stimulating factor-γ
12/15/1992	US5171674 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response
12/15/1992	US5171673 Genetic engineering to produce a desired heterologous polypeptides in gram positive bacteria
12/15/1992	US5171672 Incorporating promoter from aldehyde dehydrogenase gene; strain producing heterologous protein; culture product
12/15/1992	US5171671 Retinoic acid receptor composition
12/15/1992	US5171670 Recombinant dna method for production of parathyroid hormone
12/15/1992	US5171665 Monoclonal antibody to novel antigen associated with human tumors
12/15/1992	US5171568 Polypeptides are immunogenic, glycosylated and consists of glycoprotein B polypeptide and glycoprotein D or immunogenic fragments of glycoproteins
12/15/1992	CA2088763A1 Amplification of nucleic acid molecules
12/15/1992	CA1311431C Carbomycin biosynthetic gene, designated carg, for use in streptomycesand other organisms
12/15/1992	CA1311430C Construction of an igg binding protein to facilitate downstream processing using protein engineering
12/15/1992	CA1311429C Vector for polypeptides in bacilli
12/14/1992	CA2071105A1 Nucleotide sequences
12/12/1992	WO1992022654A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	WO1992022642A1 Universal site-specific nucleases
12/12/1992	CA2108134A1 Universal site-specific nucleases
12/12/1992	CA2087732A1 Vaccine and treatment method of human immunodeficiency virus infection
12/12/1992	CA2071015A1 Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof
12/12/1992	CA2070952A1 Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
12/11/1992	CA2044940A1 Transdominant negative proto-oncogene
12/10/1992	WO1992021972A1 Rapid screening assay for the identification of ligand-receptor interactions
12/10/1992	WO1992021781A1 Tumor suppressor
12/10/1992	WO1992021766A1 Monoclonal antibodies against c-kit
12/10/1992	WO1992021763A1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
12/10/1992	WO1992021762A1 A mouse immunoglobulin heavy-chain locus enhancer which crosshybridizes with the 3'-enhancer element of rat
12/10/1992	WO1992021761A1 Method and materials for introducing dna into prevotella ruminicola

1 ... 3864 3865 3866 3867 3868 3869 3870 3871 3872 3873 3874 3875 3876 3877 3878 3879 3880 3881 3882 3883 3884 ... 4023